ImClone Closing Branchburg, New Jersey Manufacturing Facility
08/17/2010
"This decision was made after careful consideration of a number of internal and external factors related to Erbitux [a cancer drug]," said Janice Chavers, an Eli Lilly spokesperson. "The decision was not driven by Lilly's larger restructuring effort."
ImClone currently has 90 open positions for which employees affected by the layoffs will have priority. The closure plans are effective immediately.
Project Announcements
DMR Technologies Plans Lafayette Parish, Louisiana, Manufacturing Operations
10/14/2025
Swiss-Based Hitachi Energy Expands Varennes, Canada, Operations
10/14/2025
Underwood Ammo Plans Effingham County, Georgia, Manufacturing Operations
10/14/2025
Google Plans West Memphis, Arkansas, Data Center Operations
10/14/2025
Bilt Plans New York City Headquarters Operations
10/14/2025
Smurfit Westrock Expands Saltillo, Mississippi, Manufacturing Operations
10/09/2025
Most Read
-
2025’s Top States for Business: How the Winners Are Outpacing the Rest
Q3 2025
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
The Compliance Reckoning Is Here
Q3 2025
-
Around the Horn: Data Center Supply Chains — What's Next?
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
Powering the Next Generation of Projects
Q3 2025
-
How Consumer Trends Are Reshaping Food Facilities
Q3 2025